U.S. Markets close in 6 hrs 1 min

Biolidics Limited (8YY.SI)

SES - SES Delayed Price. Currency in SGD
Add to watchlist
0.3350-0.0050 (-1.47%)
At close: 5:04PM SGT

Biolidics Limited

37 Jalan Pemimpin
No.02-07 Mapex
Singapore 577177
Singapore

http://www.biolidics.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. Man Chun Leong Ph.D.Interim Chief Exec. OfficerN/AN/AN/A
Mr. Johnson ChenFounder & Non-Exec. Non-Independent DirectorN/AN/A1973
Prof. Chwee Teck LimFounder and AdvisorN/AN/AN/A
Mr. Tan Swee JinCo-Founder and Technical AdvisorN/AN/AN/A
Mr. Wei Chee TanFinancial ControllerN/AN/A1986
Ms. Qingyin WangChief Operating OfficerN/AN/AN/A
Dr. Ali Asgar BhagatTechnical DirectorN/AN/AN/A
Ms. Sim Ving LimCompany Sec.N/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SGD.

Description

Biolidics Limited, a medical technology company, develops cell enrichment systems for cancer diagnosis, prognosis, and treatment selection and monitoring applications. The company engages in the research, experimental development, and marketing on biotechnology, life and medical science, and electronics related industrial design services. It offers ClearCell FX1 System, an automated in vitro diagnostic medical device that separates and enriches cancer cells from blood. The company has a strategic collaboration with Sysmex Corporation. It serves academic and research institutes, hospitals, and laboratories in Singapore, China, Hong Kong, Japan, the United States, and other European Union countries. The company was founded in 2009 and is based in Singapore.

Corporate Governance

Biolidics Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.